Anika Therapeutics
ANIK
#8527
Rank
A$0.40 B
Marketcap
A$30.18
Share price
1.31%
Change (1 day)
110.65%
Change (1 year)
Categories

Anika Therapeutics (ANIK) - Total debt

Total debt on the balance sheet as of March 2026 : A$35.82 Million

According to Anika Therapeutics's latest financial reports the company's total debt is A$35.82 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Anika Therapeutics - Total debt on balance sheet (from 1996 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$39.18 M-6%
2024-12-31A$41.69 M2.39%
2023-12-31A$40.71 M-10.3%
2022-12-31A$45.39 M57.05%
2021-12-31A$28.9 M-1.07%
2020-12-31A$29.21 M-9.12%
2019-12-31A$32.14 M
2018-12-31N/A
2012-12-31A$9.23 M-15.43%
2011-12-31A$10.92 M-13.32%
2010-12-31A$12.6 M-21.39%
2009-12-31A$16.03 M-29.32%
2008-12-31A$22.67 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$76.55 B 213,557.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$38.92 B 108,545.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Stryker Corporation
SYK
A$20.49 B 57,107.80%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
A$51.91 M 44.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
A$2.98 B 8,233.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Hill-Rom
HRC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA